# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 24일


## 주요 헤드라인

1. **J&J, Contineum Fail ‘Risky’ Mid-Stage Multiple Sclerosis Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-j-contineum-fail-risky-mid-stage-multiple-sclerosis-trial>

2. **UPDATE (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/gsks-tesaro-sues-anaptysbio-seeks-to-terminate-current-jemperli-contract>

3. **Moderna Cans 3 mRNA Vaccines, Secures $1.5B Loan in Quest for 10% Growth (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/moderna-cans-3-mrna-vaccines-secures-1-5b-loan-in-quest-for-10-growth>

4. **Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/eli-lilly-enters-uncharted-territory-as-market-cap-nears-1t>

5. **Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/eli-lilly-enters-uncharted-territory-as-market-cap-nears-1t>

6. **As GLP-1s Hit Bargain Bin Prices, What’s the Future of the Obesity Market? (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/as-glp-1s-hit-bargain-bin-prices-whats-the-future-of-the-obesity-market>

7. **As GLP-1s Hit Bargain Bin Prices, What’s the Future of the Obesity Market? (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/as-glp-1s-hit-bargain-bin-prices-whats-the-future-of-the-obesity-market>


---
*2025년 11월 24일 바이오스페이스 뉴스 피드에서 생성된 리포트*